SP

Sophie Perrin-Ninkovic

SP Signal Pharmaceuticals: 16 patents #13 of 207Top 7%
BS Bristol-Myers Squibb: 1 patents #2,477 of 3,969Top 65%
📍 Village of La Jolla, CA: #235 of 2,316 inventorsTop 15%
🗺 California: #35,036 of 386,348 inventorsTop 10%
Overall (All Time): #271,444 of 4,157,543Top 7%
17
Patents All Time

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDate
11306101 Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith Frans Baculi, Katherine Northcote, Matthew D. Correa, Joshua Hansen, Laurie Ann LeBrun +4 more 2022-04-19
11292796 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2022-04-05
10683298 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2020-06-16
10167290 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2019-01-01
9771371 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more 2017-09-26
9193692 Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +6 more 2015-11-24
9079900 Methods of synthesis and purification of heteroaryl compounds Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +13 more 2015-07-14
8907087 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +6 more 2014-12-09
8569494 Methods of synthesis and purification of heteroaryl compounds Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +13 more 2013-10-29
8507492 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +12 more 2013-08-13
8492381 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +12 more 2013-07-23
8372976 Methods of treatment comprising the administration of heteroaryl compounds Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Branden Lee +9 more 2013-02-12
8110578 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +12 more 2012-02-07
7981893 Heteroaryl compounds, compositions thereof, and methods of treatment therewith Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Branden Lee +9 more 2011-07-19
7589119 Methods for treating or preventing metastatic cancer using benzopyranone compounds Glenn Friedman, Jeffrey McKie, Jonathan Wright, Bernd Stein 2009-09-15
7358274 Methods for treating or preventing cancer using Benzopyranone Compounds Glenn Friedman, Jeffrey McKie, Jonathan Wright, Bernd Stein 2008-04-15
7091235 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer Glenn Friedman, Jeffrey McKie, Jonathan Wright, Bernd Stein 2006-08-15